Nadia Alatrakchi
Nadia Alatrakchi
Immunologist - Instructor in Medicine, Harvard Medical School, Massachusetts General Hospital
Adresse e-mail validée de
Citée par
Citée par
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial
RT Gandhi, L Zheng, RJ Bosch, ES Chan, DM Margolis, S Read, ...
PLoS medicine 7 (8), e1000321, 2010
Adoptive transfer of invariant NKT cells as immunotherapy for advanced melanoma: a phase I clinical trial
MA Exley, P Friedlander, N Alatrakchi, L Vriend, S Yue, T Sasada, W Zeng, ...
Clinical Cancer Research 23 (14), 3510-3519, 2017
Hepatitis C Virus (HCV)-Specific CD8+ Cells Produce Transforming Growth Factor β That Can Suppress HCV-Specific T-Cell Responses
N Alatrakchi, CS Graham, HJJ Van Der Vliet, KE Sherman, MA Exley, ...
Journal of virology 81 (11), 5882-5892, 2007
Regulatory T cells and viral liver disease
N Alatrakchi, M Koziel
Journal of viral hepatitis 16 (4), 223-229, 2009
Differentiation of exhausted CD8+ T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory
P Tonnerre, D Wolski, S Subudhi, J Aljabban, RC Hoogeveen, ...
Nature immunology 22 (8), 1030-1041, 2021
Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects
MA Exley, L Lynch, B Varghese, M Nowak, N Alatrakchi, SP Balk
Clinical immunology 140 (2), 184-195, 2011
Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication
N Alatrakchi, C Duvivier, D Costagliola, A Samri, AG Marcelin, ...
AIDS 19 (1), 25-33, 2005
Strong CD4 Th1 responses to HIV and hepatitis C virus in HIV-infected long-term non-progressors co-infected with hepatitis C virus
N Alatrakchi, V Di Martino, V Thibault, B Autran
Aids 16 (5), 713-717, 2002
Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet‐induced mouse model of nonalcoholic steatohepatitis
AJ Kruger, BC Fuchs, R Masia, JA Holmes, S Salloum, M Sojoodi, ...
Hepatology Communications 2 (5), 529-545, 2018
Macrophage activation marker soluble CD163 is a dynamic marker of liver fibrogenesis in human immunodeficiency virus/hepatitis C virus coinfection
A Lidofsky, JA Holmes, ER Feeney, AJ Kruger, S Salloum, H Zheng, ...
The Journal of infectious diseases 218 (9), 1394-1403, 2018
CD8+ Cell Responses to Hepatitis C Virus (HCV) in the Liver of Persons with HCV-HIV Coinfection versus HCV Monoinfection
N Alatrakchi, CS Graham, Q He, KE Sherman, MJ Koziel
The Journal of infectious diseases 191 (5), 702-709, 2005
Antiviral T-cell responses and therapy in chronic hepatitis B
N Alatrakchi, MJ Koziel
Journal of hepatology 39 (4), 631-634, 2003
Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and …
S Salloum, JA Holmes, R Jindal, SS Bale, C Brisac, N Alatrakchi, ...
Hepatology 64 (6), 1951-1968, 2016
Circulating soluble CD163 is associated with steatohepatitis and advanced fibrosis in nonalcoholic fatty liver disease
JL Mueller, ER Feeney, H Zheng, J Misdraji, AJ Kruger, N Alatrakchi, ...
Clinical and translational gastroenterology 6 (10), e114, 2015
Fatty acids activate the transcriptional coactivator YAP1 to promote liver fibrosis via p38 mitogen-activated protein kinase
S Salloum, AJ Jeyarajan, AJ Kruger, JA Holmes, T Shao, M Sojoodi, ...
Cellular and Molecular Gastroenterology and Hepatology 12 (4), 1297-1310, 2021
T-cell clonal expansion in patients with B-cell lymphoproliferative disorders
N Alatrakchi, F Farace, E Frau, P Carde, JN Munck, F Triebel
Journal of Immunotherapy 21 (5), 363-370, 1998
Hepatitis c virus‐specific t‐cell‐derived transforming growth factor beta is associated with slow hepatic fibrogenesis
S Li, LEM Vriend, IA Nasser, Y Popov, NH Afdhal, MJ Koziel, D Schuppan, ...
Hepatology 56 (6), 2094-2105, 2012
Proliferative, IFNγ and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection
N Alatrakchi, F Damond, S Matheron, S Beretta-Tempelhoff, P Campa, ...
Aids 20 (1), 29-34, 2006
Dynamic changes in innate immune responses during direct‐acting antiviral therapy for HCV infection
JA Holmes, C Carlton‐Smith, AY Kim, EO Dumas, J Brown, JL Gustafson, ...
Journal of Viral Hepatitis 26 (3), 362-372, 2019
Ex vivo analysis of resident hepatic pro‐inflammatory CD1d‐reactive T cells and hepatocyte surface CD1d expression in hepatitis C
K Yanagisawa, S Yue, HJ van der Vliet, R Wang, N Alatrakchi, ...
Journal of viral hepatitis 20 (8), 556-565, 2013
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20